Polyclonal Rabbit anti‑Mouse FBXL3 Antibody (C‑Terminus, IHC, WB) LS‑C144941
Polyclonal Rabbit anti‑Mouse FBXL3 Antibody (C‑Terminus, IHC, WB) LS‑C144941
Antibody:
FBXL3 Rabbit anti-Mouse Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
FBXL3 Rabbit anti-Mouse Polyclonal (C-Terminus) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
FBXL3 antibody LS-C144941 is an unconjugated rabbit polyclonal antibody to mouse FBXL3 (C-Terminus). Validated for IHC and WB.
Target
Mouse FBXL3
Synonyms
FBXL3 | F-box/LRR-repeat protein 3 | F-box/LRR-repeat protein 3A | FBL3 | FBXL3A | F-box protein Fbl3a | FBL3A
Reactivity
Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Immunogen
Synthetic peptide derived from Cter domain of mouse FBXL3 protein
Specificity
Mouse 48 kD protein
Applications
- IHC (1:50 - 1:200)
- Western blot (1:100 - 1:1000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
Lyophilized antiserum
Reconstitution
100 µl Distilled water
Storage
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Reactivity:
Human
Range:
0.31-20 ng/ml
Species:
Human
Applications:
IHC, IHC - Paraffin, ICC, Immunofluorescence, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Monkey
Range:
0.78-50 ng/ml
Reactivity:
Monkey
Range:
0.78-50 pmol/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/18/2024